Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive‐disease small cell lung cancer in the elderly and patients with poor performance status

BACKGROUND: Carboplatin plus etoposide (CE) is a standard treatment for elderly patients with extensive‐disease small cell lung cancer (ED‐SCLC). However, amrubicin monotherapy (AMR) may be a feasible alternative. We compared the efficacies and safety profiles of CE and AMR for ED‐SCLC in elderly pa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Thorac Cancer
Hlavní autoři: Igawa, Satoshi, Shirasawa, Masayuki, Ozawa, Takahiro, Nishinarita, Noriko, Okuma, Yuriko, Ono, Taihei, Sugimoto, Ai, Kurahayashi, Shintaro, Sugita, Keisuke, Sone, Hideyuki, Fukui, Tomoya, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons Australia, Ltd 2018
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6068456/
https://ncbi.nlm.nih.gov/pubmed/29870153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12772
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky